Risk Factors of Gastrointestinal Bleeding in Patients Receiving New Oral Anticoagulants
New oral anticoagulants (NOACs) are now widely used for the prevention and treatment of venous thrombosis, and for the prevention of stroke and systemic embolism in patients with atrial fibrillation. As compared with warfarin, NOACs have the advantage of rapid onset of action and less drug interacti...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Yong Chan Lee
2018-12-01
|
| Series: | The Korean Journal of Helicobacter and Upper Gastrointestinal Research |
| Subjects: | |
| Online Access: | http://www.helicojournal.org/journal/view.html?doi=10.7704/kjhugr.2018.18.4.219 |